PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Departments of Medicine and Neurology, Melbourne Brain Centre, The Royal Melbourne Hospital (N.Y., B.C.V.C., L.C.), University of Melbourne, Parkville, Australia.\', \'Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia (N.Y.).\', \'Department of Physiotherapy, Melbourne School of Health Sciences (K.S.H.), University of Melbourne, Parkville, Australia.\', \'Florey Institute of Neuroscience and Mental Health, Parkville, Australia (K.S.H., B.C.V.C.).\', \'Melbourne Medical School (L.C.), University of Melbourne, Parkville, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1161/STROKEAHA.121.036537
?:hasPublicationType
?:journal
  • Stroke
is ?:pmid of
?:pmid
?:pmid
  • 34587797
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.529
?:rankingScore_hIndex
  • 285
?:title
  • Use of the Estimand Framework to Manage the Disruptive Effects of COVID-19 on Stroke Clinical Trials.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all